Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
22%
OVERLAP
BY WEIGHT
26
# OF OVERLAPPING
HOLDINGS
XBI
119
HOLDINGS
22%
ALSO IN CANC
CANC
53
HOLDINGS
49%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
| REVOLUTION MEDICINES, INC. | 2.7% | 6.3% | 2.7% | |
| BRIDGEBIO PHARMA, INC. | 2.2% | 4.4% | 2.2% | |
| AMGEN INC | 1.7% | 2.2% | 1.7% | |
| EXELIXIS INC | 1.7% | 3.1% | 1.7% | |
| ABBVIE INC | 1.6% | 2.8% | 1.6% | |
XBI Overweight Relative to CANC
| EXACT SCIENCES CORP | 2.8% | |
| AVIDITY BIOSCIENCES INC | 2.4% | |
| NATERA INC | 2.1% | |
| INSMED INC | 2.1% | |
| MADRIGAL PHARMACEUTICALS, INC. | 2.0% | |
| ROIVANT SCIENCES LTD. | 2.0% | |
| IONIS PHARMACEUTICALS, INC. | 1.9% | |
| UNITED THERAPEUTICS CORP | 1.9% | |
| BIOGEN IDEC INC | 1.9% | |
| MODERNA, INC. | 1.9% |
XBI Underweight Relative to CANC
| ELI LILLY & CO | -5.1% | |
| ASTRAZENECA PLC | -4.3% | |
| NOVARTIS AG | -4.1% | |
| ROCHE HOLDINGS LTD-SPONS ADR | -3.9% | |
| GENMAB A/S SPONSORED ADR | -3.8% | |
| REVOLUTION MEDICINES, INC. | -3.6% | |
| BRISTOL-MYERS SQUIBB CO | -3.4% | |
| JOHNSON & JOHNSON | -3.2% | |
| COGENT BIOSCIENCES INC | -2.7% | |
| MERCK & CO. INC. | -2.7% |